@media (max-width: 768px) {
                .image-container {
                    width: 100% !important;
                    float: none !important;
                    margin: 0 0 1rem 0 !important;
                }
            }
        



Image source: The Mo

Moderna (MRNA) Q3 2026 Earnings Call Transcript

The S&P 500 Index ($SPX ) (SPY ) is up +1.07% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.09%.  December E-mini S&P futures (ESZ26 ) are up +0.90%, and December E-mini Nasdaq futures...

Stock Indexes Push Higher as Chipmakers Roar Back

The S&P 500 Index ($SPX ) (SPY ) is up +0.89% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.12%.  December E-mini S&P futures (ESZ26 ) are up +0.90%, and December E-mini Nasdaq futures...

Stocks Supported by Chipmaker Strength and a Blowout US Payroll Report

(RTTNews) - Moderna, Inc. (MRNA), a biotechnology company focused on mRNA medicines and vaccines, reported Friday third-quarter 2026 financial results, returning to profitability as revenue increased 29% year over year to $1.3 billion.

Moderna Returns To Q3 Profit; Raises FY26 Outlook On Vaccine Sales And Pipeline Progress 

(RTTNews) - Moderna, Inc (MRNA) will host a conference call at 8:00 AM ET on November 6, 2026, to discuss Q3 26 earnings results.

Moderna Q3 26 Earnings Conference Call AT 8:00 AM ET 

Key PointsModerna and Merck have developed a cancer vaccine that has been highly effective in treating melanoma patients.

Moderna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its Success

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna, Inc. News